Company Description

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China.

The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services.

It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors.

The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025.

Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Cellyan Biotechnology Co., Ltd

Country	Hong Kong
Founded	2016
IPO Date	Jan 15, 2025
Industry	Pharmaceutical Retailers
Sector	Healthcare
Employees	27
CEO	Chenyu Liang

Contact Details

Address: Well Town Industrial Building, Room B1, 5th Floor Yau Tong, 999077 Hong Kong
Phone	852 2618 9289
Website	9zt.hk

Stock Details

Ticker Symbol	HKPD
Exchange	NASDAQ
Fiscal Year	April - March
Reporting Currency	USD
IPO Price	$4.00
CIK Code	2007702
CUSIP Number	G6365B104
ISIN Number	KYG6365B1041
SIC Code	5122

Key Executives

Name	Position
Chenyu Liang	Chief Executive Officer and Director
Shu Liu	Chief Financial Officer
Zifeng Wang	Chief Strategy Officer

Latest SEC Filings

Date	Type	Title
Jan 16, 2026	6-K	Report of foreign issuer
Dec 31, 2025	6-K	Report of foreign issuer
Dec 17, 2025	6-K	Report of foreign issuer
Nov 24, 2025	6-K	Report of foreign issuer
Nov 12, 2025	6-K	Report of foreign issuer
Nov 12, 2025	SCHEDULE 13D	Filing
Oct 7, 2025	6-K	Report of foreign issuer
Sep 11, 2025	6-K	Report of foreign issuer
Aug 14, 2025	20-F	Annual and transition report of foreign private issuers
Jul 31, 2025	NT 20-F	Notification of inability to timely file Form 20-F

View All SEC Filings